On 2026-08-13, Lakewood-Amedex Biotherapeutics Inc. (LABT) announced earnings per share of $-2.75 for the fiscal quarter ending 2026-06-30, missing the average analyst estimate of $0.65.

The next expected annoucement date for quarterly earnings is 2026-11-12, with an average estimated earnings per share of $0.56 for the fiscal quarter ending 2026-09-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.